Literature DB >> 27217420

Purification of Plasmodium Sporozoites Enhances Parasite-Specific CD8+ T Cell Responses.

Zachary P Billman1,2, Annette M Seilie1,2, Sean C Murphy3,4,2.   

Abstract

Malaria infection caused by Plasmodium parasites continues to cause enormous morbidity and mortality in areas where it is endemic, and there is no licensed vaccine capable of inducing sterile protection. Hyperimmunization with attenuated whole sporozoites can induce sterile protective immune responses targeting preerythrocytic antigens. Most animal models of hyperimmunization rely on sporozoites dissected from mosquito salivary glands and injected without further purification. In BALB/c mice, repeated small doses of P. yoelii sporozoites progressively expand the population of sporozoite-specific CD8(+) T cells. In this study, large secondary doses of unpurified sporozoites unexpectedly led to contraction of sporozoite-specific CD8(+) T cell responses in sporozoite-primed mice. While sporozoite-primed CD8(+) T cells alternatively can be expanded by secondary exposure to Listeria monocytogenes expressing recombinant Plasmodium antigens, such expansion was potently inhibited by coinjection of large doses of unpurified sporozoites and by uninfected salivary glands alone. Purification of sporozoites away from mosquito salivary gland debris by density gradient centrifugation eliminated salivary gland-associated inhibition. Thus, the inhibitory effect appears to be due to exposure to uninfected mosquito salivary glands rather than sporozoites. To further assess the effect of salivary gland exposure on later sporozoite vaccinations, mice were immunized with uninfected salivary glands from a single mosquito. Compared to naive mice, salivary gland presensitization reduced subsequent liver burdens by 71%. These data show that a component(s) in mosquito salivary glands reduces liver infection, thereby limiting antigen dose and contributing to lower-magnitude T cell responses. These findings suggest that sporozoite immunogenicity studies be performed using purified sporozoites whenever feasible.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27217420      PMCID: PMC4962643          DOI: 10.1128/IAI.01439-15

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  57 in total

1.  Real-time quantitative reverse transcription PCR for monitoring of blood-stage Plasmodium falciparum infections in malaria human challenge trials.

Authors:  Sean C Murphy; Jennifer L Prentice; Kathryn Williamson; Carolyn K Wallis; Ferric C Fang; Michal Fried; Cris Pinzon; Ruobing Wang; Angela K Talley; Stefan H I Kappe; Patrick E Duffy; Brad T Cookson
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

2.  Detection of immunogenic proteins from Anopheles sundaicus salivary glands in the human serum.

Authors:  Yunita Armiyanti; Mohammad Mirza Nuryady; Renam Putra Arifianto; Elisa Nurmariana; Kartika Senjarini; Loeki Enggar Fitri; Teguh Wahju Sardjono
Journal:  Rev Soc Bras Med Trop       Date:  2015 Jul-Aug       Impact factor: 1.581

3.  Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection.

Authors:  Kent E Kester; James F Cummings; Opokua Ofori-Anyinam; Christian F Ockenhouse; Urszula Krzych; Philippe Moris; Robert Schwenk; Robin A Nielsen; Zufan Debebe; Evgeny Pinelis; Laure Juompan; Jack Williams; Megan Dowler; V Ann Stewart; Robert A Wirtz; Marie-Claude Dubois; Marc Lievens; Joe Cohen; W Ripley Ballou; D Gray Heppner
Journal:  J Infect Dis       Date:  2009-08-01       Impact factor: 5.226

4.  Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.

Authors:  Ann-Kristin Mueller; Mehdi Labaied; Stefan H I Kappe; Kai Matuschewski
Journal:  Nature       Date:  2004-12-05       Impact factor: 49.962

5.  Uninfected mosquito bites confer protection against infection with malaria parasites.

Authors:  Michael J Donovan; Andrew S Messmore; Deborah A Scrafford; David L Sacks; Shaden Kamhawi; Mary Ann McDowell
Journal:  Infect Immun       Date:  2007-03-05       Impact factor: 3.441

6.  Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites.

Authors:  Stephen L Hoffman; Lucy M L Goh; Thomas C Luke; Imogene Schneider; Thong P Le; Denise L Doolan; John Sacci; Patricia de la Vega; Megan Dowler; Chris Paul; Daniel M Gordon; Jose A Stoute; L W Preston Church; Martha Sedegah; D Gray Heppner; W Ripley Ballou; Thomas L Richie
Journal:  J Infect Dis       Date:  2002-04-01       Impact factor: 5.226

Review 7.  Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines.

Authors:  Thomas L Richie; Peter F Billingsley; B Kim Lee Sim; Eric R James; Sumana Chakravarty; Judith E Epstein; Kirsten E Lyke; Benjamin Mordmüller; Pedro Alonso; Patrick E Duffy; Ogobara K Doumbo; Robert W Sauerwein; Marcel Tanner; Salim Abdulla; Peter G Kremsner; Robert A Seder; Stephen L Hoffman
Journal:  Vaccine       Date:  2015-11-27       Impact factor: 3.641

8.  Quantitative bioluminescent imaging of pre-erythrocytic malaria parasite infection using luciferase-expressing Plasmodium yoelii.

Authors:  Jessica L Miller; Sara Murray; Ashley M Vaughan; Anke Harupa; Brandon Sack; Michael Baldwin; Ian N Crispe; Stefan H I Kappe
Journal:  PLoS One       Date:  2013-04-11       Impact factor: 3.240

9.  A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S/AS01E.

Authors:  Francis M Ndungu; Jedidah Mwacharo; Domtila Kimani; Oscar Kai; Philippe Moris; Erik Jongert; Johan Vekemans; Ally Olotu; Philip Bejon
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

10.  Successful human infection with P. falciparum using three aseptic Anopheles stephensi mosquitoes: a new model for controlled human malaria infection.

Authors:  Matthew B Laurens; Peter Billingsley; Adam Richman; Abraham G Eappen; Matthew Adams; Tao Li; Sumana Chakravarty; Anusha Gunasekera; Christopher G Jacob; B Kim Lee Sim; Robert Edelman; Christopher V Plowe; Stephen L Hoffman; Kirsten E Lyke
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

View more
  13 in total

1.  Vancomycin improves Plasmodium yoelii malaria parasite in vitro liver stage cultures by controlling Elizabethkingia anophelis, a bacterium in the microbiome of lab-reared Anopheles mosquitoes.

Authors:  Melanie J Shears; Sean C Murphy
Journal:  Mol Biochem Parasitol       Date:  2020-04-30       Impact factor: 1.759

2.  Malaria Parasite Density in Individuals with Different Rapid Diagnostic Test Results and Concentrations of HRP2 Antigen.

Authors:  Mateusz M Plucinski; Pedro Rafael Dimbu; Filomeno Fortes; Sean C Murphy; Nahum T Smith; Kurtis R Cruz; Annette M Seilie; Eric S Halsey; Michael Aidoo; Eric Rogier
Journal:  Am J Trop Med Hyg       Date:  2019-05       Impact factor: 2.345

3.  Cryopreserved Sporozoites with and without the Glycolipid Adjuvant 7DW8-5 Protect in Prime-and-Trap Malaria Vaccination.

Authors:  Felicia Watson; Melanie Shears; Jokichi Matsubara; Anya Kalata; Annette Seilie; Irene Cruz Talavera; Tayla Olsen; Moriya Tsuji; Sumana Chakravarty; B Kim Lee Sim; Stephen Hoffman; Sean Murphy
Journal:  Am J Trop Med Hyg       Date:  2022-02-28       Impact factor: 3.707

4.  Assessing drug efficacy against Plasmodium falciparum liver stages in vivo.

Authors:  Erika L Flannery; Lander Foquet; Vorada Chuenchob; Matthew Fishbaugher; Zachary Billman; Mary Jane Navarro; William Betz; Tayla M Olsen; Joshua Lee; Nelly Camargo; Thao Nguyen; Carola Schafer; Brandon K Sack; Elizabeth M Wilson; Jessica Saunders; John Bial; Brice Campo; Susan A Charman; Sean C Murphy; Margaret A Phillips; Stefan Hi Kappe; Sebastian A Mikolajczak
Journal:  JCI Insight       Date:  2018-01-11

5.  Humoral protection against mosquito bite-transmitted Plasmodium falciparum infection in humanized mice.

Authors:  Brandon K Sack; Sebastian A Mikolajczak; Matthew Fishbaugher; Ashley M Vaughan; Erika L Flannery; Thao Nguyen; Will Betz; Mary Jane Navarro; Lander Foquet; Ryan W J Steel; Zachary P Billman; Sean C Murphy; Stephen L Hoffman; Sumana Chakravarty; B Kim Lee Sim; Marije Behet; Isaie J Reuling; Jona Walk; Anja Scholzen; Robert W Sauerwein; Andrew S Ishizuka; Barbara Flynn; Robert A Seder; Stefan H I Kappe
Journal:  NPJ Vaccines       Date:  2017-10-09       Impact factor: 7.344

6.  Diagnostic challenges of prolonged post-treatment clearance of Plasmodium nucleic acids in a pre-transplant autosplenectomized patient with sickle cell disease.

Authors:  Paul M Luethy; Sean C Murphy; Annette M Seilie; Yingda L Xie; Chuen-Yen Lau; John F Tisdale; Matthew M Hsieh; Jessica L Reinhardt; Anna F Lau; Gary A Fahle
Journal:  Malar J       Date:  2018-01-10       Impact factor: 2.979

7.  Multiplex, DNase-free one-step reverse transcription PCR for Plasmodium 18S rRNA and spliced gametocyte-specific mRNAs.

Authors:  Amelia E Hanron; Zachary P Billman; Annette M Seilie; Tayla M Olsen; Matthew Fishbaugher; Ming Chang; Thomas Rueckle; Nicole Andenmatten; Bryan Greenhouse; Emmanuel Arinaitwe; John Rek; Smita Das; Gonzalo J Domingo; Kelly Shipman; Stefan H Kappe; James G Kublin; Sean C Murphy
Journal:  Malar J       Date:  2017-05-19       Impact factor: 2.979

8.  Performance of a High-Sensitivity Rapid Diagnostic Test for Plasmodium falciparum Malaria in Asymptomatic Individuals from Uganda and Myanmar and Naive Human Challenge Infections.

Authors:  Smita Das; Ihn Kyung Jang; Becky Barney; Roger Peck; John C Rek; Emmanuel Arinaitwe; Harriet Adrama; Maxwell Murphy; Mallika Imwong; Clare L Ling; Stephane Proux; Warat Haohankhunnatham; Melissa Rist; Annette M Seilie; Amelia Hanron; Glenda Daza; Ming Chang; Tomoka Nakamura; Michael Kalnoky; Paul Labarre; Sean C Murphy; James S McCarthy; Francois Nosten; Bryan Greenhouse; Sophie Allauzen; Gonzalo J Domingo
Journal:  Am J Trop Med Hyg       Date:  2017-08-18       Impact factor: 2.345

9.  Plasmodium 18S rRNA of intravenously administered sporozoites does not persist in peripheral blood.

Authors:  Sean C Murphy; Andrew S Ishizuka; Zachary P Billman; Tayla M Olsen; Annette M Seilie; Ming Chang; Nahum Smith; Vorada Chuenchob; Sumana Chakravarty; B Kim Lee Sim; Stefan H I Kappe; Stephen L Hoffman; Robert A Seder
Journal:  Malar J       Date:  2018-07-27       Impact factor: 3.469

10.  A probabilistic model of pre-erythrocytic malaria vaccine combination in mice.

Authors:  Erwan Atcheson; Karolis Bauza; Arturo Reyes-Sandoval
Journal:  PLoS One       Date:  2019-01-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.